- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma.
October 30, 2020
Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer.
October 29, 2020
Stereotactic radiotherapy combined with immune- or targeted therapy for metastatic renal cell carcinoma.
October 29, 2020
Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
October 28, 2020
Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials.
October 28, 2020
Differentiation of renal cell tumors with morphological cocktails using a minimal panel of immunohistochemical markers.
October 28, 2020
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE).
October 28, 2020
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
October 27, 2020
Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma.
October 26, 2020
Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.
October 26, 2020
Dynamic 68Ga-PSMA-11 PET/CT for the primary evaluation of localized renal mass: a prospective study.
October 26, 2020
HIF1α is not a target of 14q deletion in clear cell renal cancer.
October 22, 2020
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
October 22, 2020
Folliculin deficient renal cancer cells exhibit BRCA1 A complex expression impairment and sensitivity to PARP1 inhibitor olaparib.
October 22, 2020